Integrin-based therapeutics: biological basis, clinical use and new drugs
Crossref DOI link: https://doi.org/10.1038/nrd.2015.10
Published Online: 2016-01-29
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ley, Klaus
Rivera-Nieves, Jesus
Sandborn, William J.
Shattil, Sanford
Text and Data Mining valid from 2016-01-29
Version of Record valid from 2016-01-29
Article History
First Online: 29 January 2016
Competing interests
: W.J.S. participates in clinical trials in this area. The other authors declare no competing interests.